Ondansetron HCL 4 30S
Ended Awarded
- Contract number
- SPE2DX25FJJGW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $13,850
Award facts
- Contract value 100% obligated
- $13,850.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on August 29, 2025, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) represents a competitively awarded, firm fixed-price contract for Ondansetron HCL 4mg in quantities of 30 tablets. The contract, valued at $13,850.35, is not set-aside and is scheduled for completion by September 25, 2025. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery/Indefinite Quantity (IDIQ) prime contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of pharmaceutical and medical supply deliveries to defense and veteran healthcare systems. The company's federal contract awards consistently involve competitively awarded delivery orders with firm fixed pricing, reflecting its proven ability to meet rigorous government procurement standards across a wide spectrum of therapeutic domains. Ondansetron HCL, an antiemetic medication, supports critical healthcare needs within military medical supply chains and aligns with the company's established role as a primary pharmaceutical vendor for the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DX25FJJGW?
SPE2DX25FJJGW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 29, 2025.
How much is contract SPE2DX25FJJGW worth?
The government has obligated $13,850 on SPE2DX25FJJGW.
Is contract SPE2DX25FJJGW an order under another contract?
Yes. SPE2DX25FJJGW is a delivery order under SPE2DX15D7062, an indefinite delivery contract.
Was contract SPE2DX25FJJGW competed?
The extent of competition for SPE2DX25FJJGW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award